Sentence examples for adding incremental value from inspiring English sources

Each additional device or service, which creates that positive feedback loop of locking a user further and further down its rabbit hole, has the opportunity of adding incremental value to the company.

Nevertheless, this study provides strong support for the exploration of galectin-3 as a biomarker that may predict prognosis, whereas its usefulness in detecting heart failure or adding incremental value (over currently used clinical correlates and NT-proBNP) in the diagnostic work-up of heart failure remains unclear.

TEE can add incremental value to TTE, but may still fail to detect life-threatening signs of PHV endocarditis.

Please clearly define that strain will add incremental value to current routine assessment with TDI in finding out individuals who may develop adverse myocardial fibrosis.

The second major clinical challenge lies in determining, through appropriate studies, whether the new omics findings add incremental value to current clinical practices or clinical decision making.

Thus, our aim was to further assess whether the UKCAT is likely to add incremental value over A level (predicted or actual) attainment in the selection process.

Microvascular assessments are most likely to add incremental value in patient management to the extent that results can be applied expeditiously at the bedside.

Myocardial blood flow (MBF) measurements add incremental value to the diagnosis and evaluation of coronary artery disease (CAD) compared with qualitative perfusion imaging techniques [ 1, 4, 5].

Serial measurements of the precursor peptides of the natriuretic and vasopressin systems (midregional proatrial natriuretic peptide (MR-proANP) and C-terminal provasopressin (copeptin), respectively) should add incremental value to risk stratification in ambulatory patients with HF.

In this cohort of critically ill patients, increased echocardiographic LV end systolic volume, but not filling pressure, is a highly significant predictor of mortality that adds incremental value to APACHE III prediction.

WMSCI at peak-dose dobutamine and LVEF at rest added incremental value to the clinical parameters in predicting all-cause mortality (67 to 93 [ P < 0.0001] and 76 [ P < 0.0001], respectively).